CONMED | CNMD - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
3M USD 3.26B 1.66B 2026-03
Abbott USD 9.31B 104M 2026-03
Accuray USD 37.18M 567K 2024-12
AtriCure USD 140.72M 2.71M 2026-03
Avanos Medical USD 782.1M 625.97M 2026-03
Baxter International USD 6.04B 2.85B 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Boston Scientific USD 4.15B 107M 2026-03
CONMED USD 291.63M 44.94M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 0 2026-03
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 595.85M 49.26M 2026-03
Inogen USD 49.14M 665K 2024-09
Insulet USD 639.7M 2.2M 2026-03
Integra LifeSciences USD 1.04B 673.49M 2026-03
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Masimo USD 326.2M 2.4M 2026-03
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 337.72M 2.02M 2026-03
Olympus JPY 268.42B 35.37B 2026-03
Orthofix International USD 213.79M 12.36M 2025-12
ResMed USD 925.74M 525K 2026-03
Smith & Nephew USD 2.52B 84M 2025-12
Steris USD 1.27B 51.5M 2026-03
Stryker USD 4.92B 284M 2026-03
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 3.08B 2.55B 2026-03
Zimmer Biomet Holdings USD 1.69B 249.3M 2026-03